monoclonal antibody melanoma pembrolizumab

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
monoclonal antibody melanoma pembrolizumab	1.94	0.1	6692	27	42
monoclonal	0.39	0.5	5408	93	10
antibody	1.05	0.3	1404	16	8
melanoma	1.32	1	7434	33	8
pembrolizumab	0.69	0.5	3031	37	13

Keyword	CPC	PCC	Volume	Score
monoclonal antibody melanoma pembrolizumab	1.71	0.8	1404	36
is pembrolizumab a monoclonal antibody	1.68	0.1	8163	12
pembrolizumab in metastatic melanoma	1.9	0.5	2176	79
monoclonal antibody melanoma nivolumab	0.42	0.4	6644	27
pembrolizumab fda approval melanoma	0.82	0.1	6652	51
nivolumab and pembrolizumab for melanoma	1.72	1	2720	26
pembrolizumab versus nivolumab for melanoma	1.43	0.9	980	84
pembrolizumab vs nivolumab melanoma	0.66	0.6	440	38
monoclonal antibody melanoma ipilimumab	1.33	0.6	6191	7
neoadjuvant pembrolizumab in melanoma	1.34	0.4	582	50
pembrolizumab adjuvant melanoma nejm	0.58	0.1	251	56
monoclonal antibody melanoma clinical trials	0.22	0.8	1325	12
monoclonal antibody melanoma review	1	0.9	5382	1
monoclonal antibody melanoma immunotherapy	0.1	0.2	9690	58
pembrolizumab for stage ii melanoma	0.74	0.5	7253	9
nejm neoadjuvant pembrolizumab melanoma	1.29	0.4	7545	72
monoclonal antibody melanoma treatment	1.35	0.7	2245	61
pembrolizumab success rate melanoma	1.36	0.3	8490	2
lenvatinib and pembrolizumab melanoma	1.12	0.2	1108	90
formular terapeutic pembrolizumab melanom	0.79	0.9	6806	61
pembrolizumab in colorectal cancer	0.56	1	5212	3
pembrolizumab in cervical cancer	0.63	0.2	4411	98